Joshua Allen
Direttore Tecnico/Scientifico/R&S presso CHIMERIX, INC.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Lee T. Schalop | M | - |
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | 15 anni |
Michael Sherman | M | 58 | 5 anni | |
Michael Andriole | M | 51 | 5 anni | |
Martha Demski | F | 71 | 19 anni | |
Michelle LaSpaluto | F | 50 | 13 anni | |
Martin Stogniew | M | 69 |
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | 12 anni |
Roy W. Ware | M | - | 17 anni | |
David Jakeman | M | 47 | 15 anni | |
Victoria Vakiener | F | 60 | 3 anni | |
Lisa Decker | M | 55 | 1 anni | |
Robert Meyer | M | 65 | 6 anni | |
Clarence Machado | M | 60 | 10 anni | |
Pratik Multani | M | 57 | 4 anni | |
Michael Alrutz | M | 54 | 12 anni | |
Fred Middleton | M | 74 | 6 anni | |
Odin Naderer | M | - | 10 anni | |
Thomas Riga | M | 48 | 1 anni | |
Allen Melemed | M | 60 | 4 anni | |
Caryn Barnett | F | - | 4 anni | |
Christopher L. Jordan | M | - | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Wolfgang Oster | M | - |
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | - |
Edward F. Greissing | M | 73 | 3 anni | |
Catherine Lynch Gilliss | M | 75 | 9 anni | |
Wafik El-Deiry | M | - |
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | - |
Randall Lanier | M | - | 16 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 25 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Joshua Allen
- Contatti personali